TCF4: Difference between revisions

Jump to navigation Jump to search
(The gene is located at 18q21.2 not 18q21.1)
 
(removed Category:Human genes using HotCat)
Line 21: Line 21:
* {{cite journal | vauthors = Bain G, Murre C | title = The role of E-proteins in B- and T-lymphocyte development | journal = Seminars in Immunology | volume = 10 | issue = 2 | pages = 143–53 | date = Apr 1998 | pmid = 9618760 | doi = 10.1006/smim.1998.0116 }}
* {{cite journal | vauthors = Bain G, Murre C | title = The role of E-proteins in B- and T-lymphocyte development | journal = Seminars in Immunology | volume = 10 | issue = 2 | pages = 143–53 | date = Apr 1998 | pmid = 9618760 | doi = 10.1006/smim.1998.0116 }}
* {{cite journal | vauthors = Yerges LM, Klei L, Cauley JA, Roeder K, Kammerer CM, Moffett SP, Ensrud KE, Nestlerode CS, Marshall LM, Hoffman AR, Lewis C, Lang TF, Barrett-Connor E, Ferrell RE, Orwoll ES, Zmuda JM | display-authors = 6 | title = High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men | journal = Journal of Bone and Mineral Research | volume = 24 | issue = 12 | pages = 2039–49 | date = Dec 2009 | pmid = 19453261 | pmc = 2791518 | doi = 10.1359/jbmr.090524 }}
* {{cite journal | vauthors = Yerges LM, Klei L, Cauley JA, Roeder K, Kammerer CM, Moffett SP, Ensrud KE, Nestlerode CS, Marshall LM, Hoffman AR, Lewis C, Lang TF, Barrett-Connor E, Ferrell RE, Orwoll ES, Zmuda JM | display-authors = 6 | title = High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men | journal = Journal of Bone and Mineral Research | volume = 24 | issue = 12 | pages = 2039–49 | date = Dec 2009 | pmid = 19453261 | pmc = 2791518 | doi = 10.1359/jbmr.090524 }}
* {{cite journal | vauthors = Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P | title = Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | journal = Nature | volume = 460 | issue = 7256 | pages = 748–52 | date = Aug 2009 | pmid = 19571811 | doi = 10.1038/nature08185 }}
* {{cite journal | vauthors = Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P | title = Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | journal = Nature | volume = 460 | issue = 7256 | pages = 748–52 | date = Aug 2009 | pmid = 19571811 | doi = 10.1038/nature08185 | pmc = 3912837 }}
* {{cite journal | vauthors = Kalscheuer VM, Feenstra I, Van Ravenswaaij-Arts CM, Smeets DF, Menzel C, Ullmann R, Musante L, Ropers HH | title = Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome | journal = American Journal of Medical Genetics Part A | volume = 146A | issue = 16 | pages = 2053–9 | date = Aug 2008 | pmid = 18627065 | doi = 10.1002/ajmg.a.32419 }}
* {{cite journal | vauthors = Kalscheuer VM, Feenstra I, Van Ravenswaaij-Arts CM, Smeets DF, Menzel C, Ullmann R, Musante L, Ropers HH | title = Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome | journal = American Journal of Medical Genetics Part A | volume = 146A | issue = 16 | pages = 2053–9 | date = Aug 2008 | pmid = 18627065 | doi = 10.1002/ajmg.a.32419 }}
* {{cite journal | vauthors = Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT | display-authors = 6  | title = ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition | journal = Gastroenterology | volume = 137 | issue = 2 | pages = 639–48, 648.e1-9 | date = Aug 2009 | pmid = 19394332 | doi = 10.1053/j.gastro.2009.04.049 }}
* {{cite journal | vauthors = Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT | display-authors = 6  | title = ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition | journal = Gastroenterology | volume = 137 | issue = 2 | pages = 639–48, 648.e1-9 | date = Aug 2009 | pmid = 19394332 | doi = 10.1053/j.gastro.2009.04.049 }}
Line 37: Line 37:


[[Category:Transcription factors]]
[[Category:Transcription factors]]
[[Category:Human genes]]
[[Category:Gene expression]]
[[Category:Gene expression]]




{{gene-18-stub}}
{{gene-18-stub}}

Revision as of 02:09, 25 September 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Transcription factor 4 (TCF-4) also known as immunoglobulin transcription factor 2 (ITF-2) is a protein that in humans is encoded by the TCF4 gene located on chromosome 18q21.2.[1]

Function

TCF4 proteins act as transcription factors which will bind to the immunoglobulin enhancer mu-E5/kappa-E2 motif. TCF4 activates transcription by binding to the E-box (5’-CANNTG-3’) found usually on SSTR2-INR, or somatostatin receptor 2 initiator element. TCF4 is primarily involved in neurological development of the fetus during pregnancy by initiating neural differentiation by binding to DNA. It is found in the central nervous system, somites, and gonadal ridge during early development. Later in development it will be found in the thyroid, thymus, and kidneys while in adulthood TCF4 it is found in lymphocytes, muscles, and gastrointestinal system.[2][3]

Clinical significance

Mutations in TCF4 cause Pitt-Hopkins Syndrome (PTHS). These mutations cause TCF4 proteins to not bind to DNA properly and control the differentiation of the nervous system. In most cases that have been studied, the mutations were de novo, meaning it was a new mutation not found in other family members of the patient. Common symptoms of Pitt-Hopkins Syndrome include a wide mouth, gastrointestinal problems, developmental delay of fine motor skills, speech and breathing problems, epilepsy, and other brain defects.[4][5]

References

  1. Henthorn P, McCarrick-Walmsley R, Kadesch T (Feb 1990). "Sequence of the cDNA encoding ITF-2, a positive-acting transcription factor". Nucleic Acids Research. 18 (3): 678. doi:10.1093/nar/18.3.678. PMC 333500. PMID 2308860.
  2. de Pontual L, Mathieu Y, Golzio C, Rio M, Malan V, Boddaert N, et al. (Apr 2009). "Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome". Human Mutation. 30 (4): 669–76. doi:10.1002/humu.20935. PMID 19235238.
  3. Pscherer A, Dörflinger U, Kirfel J, Gawlas K, Rüschoff J, Buettner R, Schüle R (Dec 1996). "The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene". The EMBO Journal. 15 (23): 6680–90. PMC 452492. PMID 8978694.
  4. Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, et al. (May 2007). "Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction". American Journal of Human Genetics. 80 (5): 988–93. doi:10.1086/515582. PMC 1852736. PMID 17436254.
  5. Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, Clayton-Smith J, et al. (May 2007). "Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome)". American Journal of Human Genetics. 80 (5): 994–1001. doi:10.1086/515583. PMC 1852727. PMID 17436255.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.